Literature DB >> 19098190

Evaluation of patients with esophageal varices after endoscopic injection sclerotherapy using multiplanar reconstruction MDCT images.

Hideaki Kodama1, Hiroshi Aikata, Shintaro Takaki, Shoichi Takahashi, Naoyuki Toyota, Katsuhide Ito, Kazuaki Chayama.   

Abstract

OBJECTIVE: The purpose of our study was to assess the relationship between hemodynamic changes in portosystemic collaterals and the prognosis of patients with esophageal varices after endoscopic injection sclerotherapy using multiplanar reconstruction (MPR) MDCT images. SUBJECTS AND METHODS: The subjects of this prospective study were 53 patients who underwent endoscopic injection sclerotherapy for esophageal varices. We evaluated the reconstructed MPR images of portosystemic collaterals before and after endoscopic injection sclerotherapy. Patients were divided into three groups based on the rate of change in the diameter of the feeding vessel into complete eradication (group A), narrowing (group B), and no change (group C). We analyzed the relationship between hemodynamic change in portosystemic collaterals and prognosis.
RESULTS: The left gastric vein, posterior gastric vein, and left gastric vein plus posterior gastric vein were the main feeding vessels (n=44 [83%] of patients, n=5 [9%], and n=4 [8%], respectively). The proportions of patients of groups A, B, and C were 19% (n=10), 24% (n=13), and 57% (n=30), respectively. The relapse-free rates at 2 years after endoscopic injection sclerotherapy were 100%, 65%, and 52% in groups A, B, and C, respectively (p<0.05). For group C, the relapse-free rate at 2 years after endoscopic injection sclerotherapy of patients with a large-diameter paraesophageal vein (>or= 3 mm, 63%) was significantly higher than in those with a small-diameter paraesophageal vein (<3 mm, 36%; p<0.05). However, there were no significant differences in the survival rate among the three groups.
CONCLUSION: MPR MDCT images on portosystemic collaterals can accurately predict relapse of esophageal varices after endoscopic injection sclerotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19098190     DOI: 10.2214/AJR.08.1268

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis.

Authors:  Yuko Nagaoki; Hiroshi Aikata; Tomoki Kobayashi; Takayuki Fukuhara; Keiichi Masaki; Mio Tanaka; Noriaki Naeshiro; Takashi Nakahara; Yohji Honda; Daisuke Miyaki; Tomokazu Kawaoka; Shintaro Takaki; Masataka Tsuge; Akira Hiramatsu; Michio Imamura; Hideyuki Hyogo; Yoshiiku Kawakami; Shoichi Takahashi; Hidenori Ochi; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2012-10-05       Impact factor: 7.527

2.  Radiological score for hemorrhage in the patients with portal hypertension.

Authors:  Wei Ge; Yi Wang; Ya-Juan Cao; Min Xie; Yi-Tao Ding; Ming Zhang; De-Cai Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Effect of intravariceal sclerotherapy combined with esophageal mucosal sclerotherapy using small-volume sclerosant for cirrhotic patients with high variceal pressure.

Authors:  De-Run Kong; Jin-Guang Wang; Chen Chen; Fang-Fang Yu; Qiong Wu; Jian-Ming Xu
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

4.  Gastroesophageal Variceal Bleeding Successfully Controlled by Partial Splenic Embolization.

Authors:  Takayuki Kogure; Jun Inoue; Eiji Kakazu; Masashi Ninomiya; Tooru Shimosegawa
Journal:  Intern Med       Date:  2017-06-01       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.